Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids-Reference-Cited by-同舟云学术

Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

Published:2015-10-23 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Freedman Benjamin S.,Brooks Craig R.,Lam Albert Q.,Fu Hongxia,Morizane Ryuji,Agrawal Vishesh,Saad Abdelaziz F.,Li Michelle K.,Hughes Michael R.,Werff Ryan Vander,Peters Derek T.,Lu Junjie,Baccei Anna,Siedlecki Andrew M.,Valerius M. Todd,Musunuru Kiran,McNagny Kelly M.,Steinman Theodore I.,Zhou Jing,Lerou Paul H.,Bonventre Joseph V.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms9715.pdf

Reference54 articles.

1. Bryant, D. M. et al. A molecular network for de novo generation of the apical surface and lumen. Nat. Cell Biol. 12, 1035–1045 (2010).

2. Steiner, D. et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 28, 361–364 (2010).

3. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

4. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).

5. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).

Cited by 613 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. Generating kidney organoids based on developmental nephrology;European Journal of Cell Biology;2024-12

3. Progress and breakthroughs in human kidney organoid research;Biochemistry and Biophysics Reports;2024-09

4. Complex in vitro models positioned for impact to drug testing in pharma: a review;Biofabrication;2024-08-27

5. KCNJ16-depleted kidney organoids recapitulate tubulopathy and lipid recovery upon statins treatment;Stem Cell Research & Therapy;2024-08-26